Clinical Chemistry
Specimens
1 liquid or lyophilised human serum preparation.
Examinations
Lp(a).
Important Notes
Microbiology
Specimens
2 plasma or serum samples, 0.5 mL. Authentic single human donor samples.
Examinations
HBsAb (anti-HBs), quantitative
Important Notes
Microbiology
Specimens
3 whole blood samples. The scheme contains primarily Plasmodium falciparum positive and negative samples, occasionally other Plasmodium species are included.
Examinations
Antigen and nucleic acid detection. Target antigens: HRP2 and/or pLDH and/or aldolase.
Important Notes
For clinical laboratories and POCT sites.
Microbiology
Specimens
2 methanol fixed or Giemsa stained smears. Brief case histories also given
Examinations
Preliminary screening of malaria plasmodia
Important Notes
Microbiology
Specimens
2 methanol fixed or May-Grünwald-Giemsa stained smears. Brief case histories are also given
Examinations
Preliminary screening of malaria plasmodia
Important Notes
Clinical Chemistry
Specimens
2 lyophilised samples
Examinations
AFP, b-hCG, inhibini A, PAPP-A, total hCG, unconjugated estriol
Important Notes
Microbiology
Specimens
3 plasma or serum samples, 0.5 mL.
Examinations
Measles virus IgG and IgM antibodies and post-analytical clinical interpretation
Important Notes
Multiplex
Specimens
3 simulated samples, 1 mL.
Examinations
Direct multiplex nucleic acid detection. Pathogens included are Escherichia coli K1, Haemophilus influenzae, Listeria monocytogenes, Neisseria meningitidis, Streptococcus agalactiae, Streptococcus pneumoniae, Cytomegalovirus (CMV), Enterovirus, Epstein-Barr virus (EBV), Herpes simplex virus 1 (HSV1), Herpes simplex virus 2 (HSV2), Human herpesvirus 6 (HHV6), Human parechovirus (HPeV), Varizella zoster virus (VZV) Cryptococcus neoformans and Cryptococcus gattii.
Important Notes
During the period of one calendar year, a comprehensive selection of listed pathogens will be covered.
Clinical Chemistry
Specimens
2 serum samples 1.5 mL each
Examinations
P-Methylmalonat
Important Notes
Organised in co-operation with DEKS. Participation in all rounds is required. All samples are distributed in February. Register orders before the end of December. Four rounds per year.
Microbiology
Specimens
2 swab samples simulating patient samples from lesions
Examinations
Mpox NAT
Important Notes
The samples contain hDNA.
Microbiology
Specimens
3 simulated samples
Examinations
Influenza A/B virus NAT, RSV NAT and SARS-CoV-2 NAT
Important Notes
The scheme is not suitable for TMA methods (e.g. Hologic Aptima SARS-CoV-2 Assay). The samples contain hDNA.
Microbiology
Specimens
3 plasma or serum samples, 0.5 mL.
Examinations
Mumps virus IgG and IgM antibodies and post-analytical clinical interpretation
Important Notes